S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)

TherapeuticsMD (TXMD) Earnings Date, Estimates & Call Transcripts

$2.58
-0.21 (-7.53%)
(As of 11/30/2023 ET)
Compare
Today's Range
$2.58
▼
$2.84
50-Day Range
$2.00
▼
$3.08
52-Week Range
$1.95
▼
$7.18
Volume
16,988 shs
Average Volume
30,377 shs
Market Capitalization
$27.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TXMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TXMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TXMD Earnings Date and Information

TherapeuticsMD has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 5th, 2024 based off prior year's report dates.

TherapeuticsMD Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/5/2024
Estimated)		------- 
8/14/2023Q2 2023($0.07)($0.24)($0.17)($0.24)-$0.44 million
5/15/2023Q1 2023-($0.24)($0.24)($0.11)-$0.42 million
11/14/2022Q3 2022($2.04)($3.13)($1.09)($3.13)$30.20 million$20.92 million
8/15/2022Q2 2022($3.04)($2.15)+$0.89($16.69)$23.20 million$28.56 million    
5/16/2022Q1 2022($3.50)($4.72)($1.22)($3.75)$19.61 million$19.33 million
5/16/2022Q1 2022($3.50)($4.72)($1.22)($3.75)$19.61 million$19.33 million  
3/10/2022Q4 2021($0.06)($0.09)($0.03)($0.08)$30.07 million$18.68 million
3/10/2022Q4 2021($3.00)($4.50)($1.50)($0.08)$30.07 million$18.68 million    
11/11/2021Q3 2021($0.10)($0.11)($0.01)($0.11)$26.65 million$25.41 million
11/11/2021Q3 2021($5.00)($5.50)($0.50)($0.11)$26.65 million$25.41 million    
8/4/2021Q2 2021($0.11)($0.11)-($0.11)$22.63 million$23.00 million
8/4/2021Q2 2021($5.50)($5.50)-($0.11)$22.63 million$23.00 million    
5/6/2021Q1 2021($0.10)($0.11)($0.01)($0.11)$20.22 million$19.87 million
5/6/2021Q1 2021($5.00)($5.50)($0.50)($0.11)$20.22 million$19.87 million  
3/2/2021Q4 2020($0.10)($0.15)($0.05)($0.15)$21.28 million$22.58 million
3/1/2021Q4 2020($5.00)($7.50)($2.50)($0.15)$21.28 million$22.58 million  












TherapeuticsMD Earnings - Frequently Asked Questions

When is TherapeuticsMD's earnings date?

TherapeuticsMD has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 5th, 2024 based off last year's report dates. Learn more on TXMD's earnings history.

How much revenue does TherapeuticsMD generate each year?

TherapeuticsMD (NASDAQ:TXMD) has a recorded annual revenue of $69.96 million.

How much profit does TherapeuticsMD generate each year?

TherapeuticsMD (NASDAQ:TXMD) has a recorded net income of $112 million. TXMD has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:TXMD) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -